1st Circ. Lets Feds Join Arguments In Pfizer FCA Suit

Law360, Chicago (April 10, 2012, 7:04 PM EDT) -- The First Circuit ruled Tuesday that the U.S. can take part in oral arguments in a former Pfizer Inc. executive's bid to resurrect his False Claims Act suit alleging the company shelled out kickbacks to doctors who prescribed its human growth hormone drug Genotropin.

The federal government, which declined to intervene in the suit but filed an amicus curiae brief, asked the court on March 30 to allow it to participate in the arguments, saying that it has a substantial interest in the proper interpretation of...
To view the full article, register now.